Harmony Biosciences Holdings (HRMY) Enterprise Value (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported Enterprise Value of -$523.9 million for Q1 2026, down 3.34% on a YoY basis from -$542.0 million in Q1 2025, and down 38.44% sequentially from -$378.4 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Enterprise Value (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 8 years of Enterprise Value data on file, last reported at -$523.9 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 3.34% year-over-year to -$523.9 million; the trailing twelve-month figure through Mar 2026 stood at -$523.9 million (down 3.34% YoY), and the FY2025 full-year result was -$378.4 million, up 14.15% from the prior year.
- Enterprise Value eased to -$523.9 million in Q1 2026, from -$378.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$212.2 million in Q2 2022 to a low of -$672.6 million in Q3 2025.
- A 5-year average of -$405.3 million and a median of -$378.4 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value tumbled 74.82% in 2023 and rose 14.15% in 2025, its largest moves.
- Tracing HRMY's Enterprise Value over 5 years: stood at -$366.2 million in 2022, then gained by 3.48% to -$353.5 million in 2023, then declined by 24.71% to -$440.8 million in 2024, then climbed by 14.15% to -$378.4 million in 2025, then sank by 38.44% to -$523.9 million in 2026.
- Business Quant data shows HRMY's Enterprise Value at -$523.9 million in Q1 2026, -$378.4 million in Q4 2025, and -$672.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | -523.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -523.89 Mn |
| Dec 31, 2025 | -378.41 Mn |
| Sep 30, 2025 | -672.58 Mn |
| Jun 30, 2025 | -565.27 Mn |
| Mar 31, 2025 | -506.95 Mn |
| Dec 31, 2024 | -440.79 Mn |
| Sep 30, 2024 | -410.48 Mn |
| Jun 30, 2024 | -417.40 Mn |
| Mar 31, 2024 | -424.06 Mn |
| Dec 31, 2023 | -353.46 Mn |
| Sep 30, 2023 | -370.67 Mn |
| Jun 30, 2023 | -370.98 Mn |
| Mar 31, 2023 | -343.88 Mn |
| Dec 31, 2022 | -366.21 Mn |
| Sep 30, 2022 | -307.76 Mn |
| Jun 30, 2022 | -212.21 Mn |
| Mar 31, 2022 | -224.50 Mn |
| Dec 31, 2021 | -234.31 Mn |
| Sep 30, 2021 | -189.70 Mn |
| Jun 30, 2021 | -159.69 Mn |